Filing Details
- Accession Number:
- 0001209191-20-050340
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-14 19:34:20
- Reporting Period:
- 2020-09-10
- Accepted Time:
- 2020-09-14 19:34:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651944 | Dermtech Inc. | DMTK | Services-Medical Laboratories (8071) | 842870849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1807311 | Claudia Ibarra | C/O Dermtech, Inc. 11099 N. Torrey Pines Rd. Suite 100 La Jolla CA 92037 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-10 | 4,802 | $10.57 | 120,470 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-10 | 2,803 | $11.25 | 117,667 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.
- This transaction was executed in multiple trades at prices ranging from $10.20 to $10.895, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $10.90 to $11.89, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.